Dozens of people sue GLP-1 drug companies over alleged vision loss

Dozens of people have filed lawsuits in the United States against GLP-1 companies, claiming their products, such as Ozempic and Mounjaro, caused a rare condition called NAION, leading to permanent vision loss. Companies like Novo Nordisk and Eli Lilly contest the allegations, while scientific research on the link between these drugs and NAION remains mixed. One plaintiff in Pennsylvania described her vision as looking through a 'fishbowl' after taking the medications.